Manufacturer of Controlled Substances; Notice of Application, 47962 [E9-22503]
Download as PDF
<![CDATA[
47962
Federal Register / Vol. 74, No. 180 / Friday, September 18, 2009 / Notices
the basic classes of controlled
substances listed.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Dated: September 14, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–22505 Filed 9–17–09; 8:45 am]
BILLING CODE 4410–09–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances
Notice of Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances
Notice of Registration
Manufacturer of Controlled
Substances; Notice of Application
By Notice dated June 15, 2009, and
published in the Federal Register on
June 24, 2009, (74 FR 30111), AllTech
Associates Inc., 2051 Waukegan Road,
Deerfield, Illinois 60015, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
schedules I and II:
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 2, 2009, GE
Healthcare, 3350 North Ridge Avenue,
Arlington Heights, Illinois 60004–1412,
made application by renewal to the
Drug Enforcement Administration
(DEA) as a bulk manufacturer of Cocaine
(9041), a basic class of controlled
substance in schedule II.
The company plans to manufacture a
radioactive product used in diagnostic
imaging in the diagnosis of Parkinson’s
Disease and for manufacture in bulk for
investigational new drug (IND)
submission and clinical trials.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such a substance,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, VA 22152; and must be
filed no later than November 17, 2009.
erowe on DSK5CLS3C1PROD with NOTICES
By Notice dated June 15, 2009, and
published in the Federal Register on
June 23, 2009 (74 FR 29718), Aptuit,
10245 Hickman Mills Drive, Kansas
City, Missouri 64137, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of Marihuana (7360), a basic
class of controlled substance listed in
schedule I.
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for packaging for a clinical trial
study.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a)
and determined that the registration of
Aptuit to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Aptuit to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
The company plans to import these
controlled substances for the
manufacture of reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and § 952(a)
and determined that the registration of
AllTech Associates, Inc. to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated AllTech
Associates, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: September 11, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–22451 Filed 9–17–09; 8:45 am]
Dated: September 11, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–22452 Filed 9–17–09; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
VerDate Nov<24>2008
15:10 Sep 17, 2009
Jkt 217001
Drug
Schedule
Gamma
Hydroxybutyric
Acid
(2010).
Heroin (9200) ...............................
Cocaine (9041) .............................
Codeine (9050) .............................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
I
I
II
II
II
II
II
II
Dated: September 14, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–22503 Filed 9–17–09; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances Notice of Registration
By Notice dated June 3, 2009, and
published in the Federal Register on
June 9, 2009, (74 FR 27350), Norac Inc.,
405 S. Motor Avenue, P.O. Box 577,
Azusa, California 91702–3232, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Nabilone (7379), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the bulk controlled substance for use in
product development and for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 74, Number 180 (Friday, September 18, 2009)]
[Notices]
[Page 47962]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-22503]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 2, 2009, GE Healthcare,
3350 North Ridge Avenue, Arlington Heights, Illinois 60004-1412, made
application by renewal to the Drug Enforcement Administration (DEA) as
a bulk manufacturer of Cocaine (9041), a basic class of controlled
substance in schedule II.
The company plans to manufacture a radioactive product used in
diagnostic imaging in the diagnosis of Parkinson's Disease and for
manufacture in bulk for investigational new drug (IND) submission and
clinical trials.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such a substance, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, VA 22152; and must be filed no later
than November 17, 2009.
Dated: September 14, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-22503 Filed 9-17-09; 8:45 am]
BILLING CODE 4410-09-P
